85 related articles for article (PubMed ID: 2944241)
1. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis.
Scharrer IM; Wohl RC; Hach V; Sinio L; Boreisha I; Robbins KC
Thromb Haemost; 1986 Jun; 55(3):396-401. PubMed ID: 2944241
[TBL] [Abstract][Full Text] [Related]
2. Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis.
Scharrer I; Hach-Wunderle V; Wohl RC; Sinio L; Boreisha I; Robbins KC
Haemostasis; 1988; 18 Suppl 1():77-86. PubMed ID: 2965086
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen San Antonio: an abnormal plasminogen with a more cathodic migration, decreased activation and associated thrombosis.
Liu Y; Lyons RM; McDonagh J
Thromb Haemost; 1988 Feb; 59(1):49-53. PubMed ID: 3363534
[TBL] [Abstract][Full Text] [Related]
4. Abnormal plasminogen Maywood I.
Robbins KC; Boreisha IG; Godwin JE
Thromb Haemost; 1991 Nov; 66(5):575-80. PubMed ID: 1803622
[TBL] [Abstract][Full Text] [Related]
5. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.
Aoki N; Moroi M; Sakata Y; Yoshida N; Matsuda M
J Clin Invest; 1978 May; 61(5):1186-95. PubMed ID: 659588
[TBL] [Abstract][Full Text] [Related]
6. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
7. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
8. [Plasminogen deficiencies in 2 Spanish families. Response to the administration of DDAVP].
Tabernero MD; Galende J; Tomás JF; Alberca I; Estelles A; Vicente V
Sangre (Barc); 1990 Apr; 35(2):137-41. PubMed ID: 2363094
[TBL] [Abstract][Full Text] [Related]
9. Congenital deficiency of plasminogen and its relationship to venous thrombosis.
Hach-Wunderle V; Scharrer I; Lottenberg R
Thromb Haemost; 1988 Apr; 59(2):277-80. PubMed ID: 3388298
[TBL] [Abstract][Full Text] [Related]
10. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain.
Boivin D; Provençal M; Gendron S; Ratel D; Demeule M; Gingras D; Béliveau R
Arch Biochem Biophys; 2004 Nov; 431(2):197-206. PubMed ID: 15488468
[TBL] [Abstract][Full Text] [Related]
12. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
Bangert K; Thorsen S
Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
[TBL] [Abstract][Full Text] [Related]
13. Human plasminogen variant Chicago III.
Wohl RC; Summaria L; Chediak J; Rosenfeld S; Robbins KC
Thromb Haemost; 1982 Oct; 48(2):146-52. PubMed ID: 6217576
[No Abstract] [Full Text] [Related]
14. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
15. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
Summaria L; Boreisha I; Barlow GH; Robbins KC
Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
[TBL] [Abstract][Full Text] [Related]
16. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
Tran-Thang C; Kruithof EK; Bachmann F
J Clin Invest; 1984 Dec; 74(6):2009-16. PubMed ID: 6210307
[TBL] [Abstract][Full Text] [Related]
17. Plasma fibrinolytic activity in a group of hypogonadic men.
Bennet A; Sie P; Caron P; Boneu B; Bazex J; Pontonnier F; Barret A; Louvet JP
Scand J Clin Lab Invest; 1987 Feb; 47(1):23-7. PubMed ID: 2953061
[TBL] [Abstract][Full Text] [Related]
18. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
Poon IK; Olsson AK; Hulett MD; Parish CR
Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
[TBL] [Abstract][Full Text] [Related]
19. Classification of abnormal plasminogens: dysplasminogenemias.
Robbins KC
Semin Thromb Hemost; 1990 Jul; 16(3):217-20. PubMed ID: 2146745
[No Abstract] [Full Text] [Related]
20. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
